missing translation for 'onlineSavingsMsg'
Learn More

STEMCELL Technologies AZ628​

Product Code. 17160152
Encompass_Preferred
Change view
Click to view available options
Quantity:
1 mg
Unit Size:
1mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
17160152 1 mg 1mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 17160152 Supplier STEMCELL Technologies Supplier No. 72982

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MEK/ERK pathway inhibitor; Inhibits B-RAF, B-RAFV600E, and C-RAF-1

  • AZ628 is a quinazolinone that inhibits several Rapidly accelerated fibrosarcoma (RAF) kinases, including B-RAF, B-RAF V600E, and C-RAF-1 (in vitro kinase assay IC50 values of 105, 34, and 29 nM respectively; Khazak et al.) It strongly promotes B-Raf dimerization as a tight-binding inhibitor with a very slow off rate (Hatzivassiliou et al.; Lavoie et al.) From specificity profiling it is known to prevent activation of several other tyrosine kinases, including kinase insert domain receptor (KDR), discoidin domain receptor 2 (DDR2), Lck/Yes Novel (LYN), feline McDonough sarcoma (FMS), and FMS-like tyrosine kinase 1 (FLT1) (Khazak et al.)
  • Inhibits tumor growth, induces cell cycle arrest and causes apoptosis in a variety of cancer cell lines, especially in lines with the B-RAF V600E mutation (McDermott et al.; Khazak et al.)

Specifications

CAS 878739-06-1
Quantity 1 mg
Molecular Formula C27H25N5O2
Purity ≥98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.